Cargando…
Modified Huo-Luo-Xiao-Ling Dan Suppresses Adjuvant Arthritis by Inhibiting Chemokines and Matrix-Degrading Enzymes
Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting the joints that can lead to deformities and disability. The prolonged use of conventionally used drugs is associated with severe adverse reactions. Therefore, safer and less expensive therapeutic products are continually being sou...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310235/ https://www.ncbi.nlm.nih.gov/pubmed/22474510 http://dx.doi.org/10.1155/2012/589256 |
_version_ | 1782227631699132416 |
---|---|
author | Nanjundaiah, Siddaraju M. Lee, David Y.-W. Ma, Zhongze Fong, Harry H. S. Lao, Lixing Berman, Brian M. Moudgil, Kamal D. |
author_facet | Nanjundaiah, Siddaraju M. Lee, David Y.-W. Ma, Zhongze Fong, Harry H. S. Lao, Lixing Berman, Brian M. Moudgil, Kamal D. |
author_sort | Nanjundaiah, Siddaraju M. |
collection | PubMed |
description | Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting the joints that can lead to deformities and disability. The prolonged use of conventionally used drugs is associated with severe adverse reactions. Therefore, safer and less expensive therapeutic products are continually being sought. Huo-Luo-Xiao-Ling dan (HLXL), a traditional Chinese herbal mixture, and its modified versions possess anti-arthritic activity. In this paper, we examined the influence of modified HLXL on two of the key mediators of arthritic inflammation and tissue damage, namely, chemokines and matrix-metalloproteinases (MMPs) in the rat adjuvant-induced arthritis (AA) model of RA. We treated arthritic Lewis rats with HLXL (2.3 g/kg) by daily gavage beginning at the onset of AA. The control rats received the vehicle. At the peak phase of AA, rats were sacrificed and their draining lymph node cells (LNC) and spleen adherent cells (SAC) were tested. The HLXL-treated rats showed a significant reduction in the levels of chemokines (RANTES, MCP-1, MIP-1α, and GRO/KC), MMPs (MMP 2 and 9), as well as cytokines (IL-6 and IL-17) that induce them, compared to the control vehicle-treated rats. Thus, HLXL controls arthritis in part by suppressing the mediators of immune pathology, and it might offer a promising alternative/adjunct treatment for RA. |
format | Online Article Text |
id | pubmed-3310235 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33102352012-04-03 Modified Huo-Luo-Xiao-Ling Dan Suppresses Adjuvant Arthritis by Inhibiting Chemokines and Matrix-Degrading Enzymes Nanjundaiah, Siddaraju M. Lee, David Y.-W. Ma, Zhongze Fong, Harry H. S. Lao, Lixing Berman, Brian M. Moudgil, Kamal D. Evid Based Complement Alternat Med Research Article Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting the joints that can lead to deformities and disability. The prolonged use of conventionally used drugs is associated with severe adverse reactions. Therefore, safer and less expensive therapeutic products are continually being sought. Huo-Luo-Xiao-Ling dan (HLXL), a traditional Chinese herbal mixture, and its modified versions possess anti-arthritic activity. In this paper, we examined the influence of modified HLXL on two of the key mediators of arthritic inflammation and tissue damage, namely, chemokines and matrix-metalloproteinases (MMPs) in the rat adjuvant-induced arthritis (AA) model of RA. We treated arthritic Lewis rats with HLXL (2.3 g/kg) by daily gavage beginning at the onset of AA. The control rats received the vehicle. At the peak phase of AA, rats were sacrificed and their draining lymph node cells (LNC) and spleen adherent cells (SAC) were tested. The HLXL-treated rats showed a significant reduction in the levels of chemokines (RANTES, MCP-1, MIP-1α, and GRO/KC), MMPs (MMP 2 and 9), as well as cytokines (IL-6 and IL-17) that induce them, compared to the control vehicle-treated rats. Thus, HLXL controls arthritis in part by suppressing the mediators of immune pathology, and it might offer a promising alternative/adjunct treatment for RA. Hindawi Publishing Corporation 2012 2012-03-07 /pmc/articles/PMC3310235/ /pubmed/22474510 http://dx.doi.org/10.1155/2012/589256 Text en Copyright © 2012 Siddaraju M. Nanjundaiah et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Nanjundaiah, Siddaraju M. Lee, David Y.-W. Ma, Zhongze Fong, Harry H. S. Lao, Lixing Berman, Brian M. Moudgil, Kamal D. Modified Huo-Luo-Xiao-Ling Dan Suppresses Adjuvant Arthritis by Inhibiting Chemokines and Matrix-Degrading Enzymes |
title | Modified Huo-Luo-Xiao-Ling Dan Suppresses Adjuvant Arthritis by Inhibiting Chemokines and Matrix-Degrading Enzymes |
title_full | Modified Huo-Luo-Xiao-Ling Dan Suppresses Adjuvant Arthritis by Inhibiting Chemokines and Matrix-Degrading Enzymes |
title_fullStr | Modified Huo-Luo-Xiao-Ling Dan Suppresses Adjuvant Arthritis by Inhibiting Chemokines and Matrix-Degrading Enzymes |
title_full_unstemmed | Modified Huo-Luo-Xiao-Ling Dan Suppresses Adjuvant Arthritis by Inhibiting Chemokines and Matrix-Degrading Enzymes |
title_short | Modified Huo-Luo-Xiao-Ling Dan Suppresses Adjuvant Arthritis by Inhibiting Chemokines and Matrix-Degrading Enzymes |
title_sort | modified huo-luo-xiao-ling dan suppresses adjuvant arthritis by inhibiting chemokines and matrix-degrading enzymes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310235/ https://www.ncbi.nlm.nih.gov/pubmed/22474510 http://dx.doi.org/10.1155/2012/589256 |
work_keys_str_mv | AT nanjundaiahsiddarajum modifiedhuoluoxiaolingdansuppressesadjuvantarthritisbyinhibitingchemokinesandmatrixdegradingenzymes AT leedavidyw modifiedhuoluoxiaolingdansuppressesadjuvantarthritisbyinhibitingchemokinesandmatrixdegradingenzymes AT mazhongze modifiedhuoluoxiaolingdansuppressesadjuvantarthritisbyinhibitingchemokinesandmatrixdegradingenzymes AT fongharryhs modifiedhuoluoxiaolingdansuppressesadjuvantarthritisbyinhibitingchemokinesandmatrixdegradingenzymes AT laolixing modifiedhuoluoxiaolingdansuppressesadjuvantarthritisbyinhibitingchemokinesandmatrixdegradingenzymes AT bermanbrianm modifiedhuoluoxiaolingdansuppressesadjuvantarthritisbyinhibitingchemokinesandmatrixdegradingenzymes AT moudgilkamald modifiedhuoluoxiaolingdansuppressesadjuvantarthritisbyinhibitingchemokinesandmatrixdegradingenzymes |